ULTIMUM™ 407843Recalls & reported problems
St. Jude Medical, Inc. · HEMOSTASIS INTRODUCER5F-ACT · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 05414734011051), received between Aug 3, 2018 and Jun 13, 2023 — classified as 8 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (7 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak7
- Difficult to Insert1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient3
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 13, 2023Fluid/Blood Leak; Fluid/Blood Leak
RELATED MANUFACTURING REF: 3005334138-2023-00268. DURING AN ADRENAL ARTERY EMBOLIZATION PROCEDURE, A BLOOD LEAK WAS NOTED FROM THE HEMOSTATIC VALVE OF 2 DEVICES. A THIRD INTRODUCER WAS USED TO COMPLETE THE PROCEDURE WITH NO CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17119433 ↗MalfunctionJun 13, 2023Fluid/Blood Leak; Fluid/Blood Leak
RELATED MANUFACTURING REF: 3005334138-2023-00269. DURING AN ADRENAL ARTERY EMBOLIZATION PROCEDURE, A BLOOD LEAK WAS NOTED FROM THE HEMOSTATIC VALVE OF 2 DEVICES. A THIRD INTRODUCER WAS USED TO COMPLETE THE PROCEDURE WITH NO CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17119408 ↗MalfunctionJun 5, 2023Fluid/Blood Leak; Fluid/Blood Leak
DURING A TRANSARTERIAL CHEMOEMBOLIZATION PROCEDURE VIA FEMORAL ACCESS, A BLOOD LEAK WAS NOTED FROM THE HEMOSTATIC VALVE. ANOTHER DEVICE WAS USED TO COMPLETE THE PROCEDURE WITH NO CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17058575 ↗MalfunctionJul 20, 2022Fluid/Blood Leak; Fluid/Blood Leak
DURING A PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA PROCEDURE, A BLOOD LEAK OCCURRED FROM THE HEMOSTASIS VALVE OF THE INTRODUCER WHEN CATHETER WAS REMOVED. AN ANGIOSEAL DEVICE WAS THEN USED TO ACHIEVE HEMOSTASIS. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH NO ADVERSE CONSEQUENCES.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15066062 ↗MalfunctionMar 3, 2022Difficult to Insert; Difficult to Insert
DURING AN EXPLORATORY PROCEDURE BY CATHETERIZATION OF THE ADRENAL VEINS FOR PRIMARY HYPERALDOSTERONISM FOR A PATIENT WITH A HISTORY OF ARTERIAL HYPERTENSION, INITIALLY BOTH THE NON-ABBOTT CATHETER AND CATHETER GUIDE WERE ABLE TO BE INSERTED THROUGH THE INTRODUCER. UPON RE-ENTRANCE, THE CATHETER AND THE CATHETER GUIDE WERE NOT ABLE TO BE FULLY INSERTED INTO THE INTRODUCER. EVENTUALLY THE CATHETER WAS ABLE TO PASS THROUGH THE INTRODUCER PARTIALLY, WHICH ALLOWED MANIPULATION OF THE CATHETER. BECAUSE OF THE ISSUE, A PROLONGATION OF THE INTERVENTION AND ADDITIONAL STRESS ON THE PATIENT OCCURRED DUE TO THE PATIENT BEING UNDER LOCAL ANESTHESIA FOR THE PROCEDURE. THERE WERE NO ADVERSE CONSEQUENCES TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13663452 ↗MalfunctionJun 16, 2020Fluid/Blood Leak; Fluid/Blood Leak
DURING THE PROCEDURE, THE SHEATH WAS PLACED WITHOUT THE GUIDEWIRE AND A BLOOD LEAK WAS NOTED FROM THE HEMOSTASIS VALVE. THE DEVICE WAS REPLACED AND THE PROCEDURE WAS COMPLETED WITH NO CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10158299 ↗MalfunctionOct 23, 2019Fluid/Blood Leak; Fluid/Blood Leak
AFTER THE PUNCTURE WAS PERFORMED, THE CATHETER WAS PLACED INSIDE THE SHEATH, AND THE VALVE WAS LEAKING BLOOD. ANOTHER SHEATH WAS USED TO CONTINUE AND COMPLETE THE PROCEDURE WITH NO PATIENT CONSEQUENCES.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9224553 ↗MalfunctionAug 3, 2018Fluid/Blood Leak; Fluid/Blood Leak
THE VALVE ON THE ULTIMUM HEMOSTASIS INTRODUCER WAS DEFECTIVE AND THE DEVICE LEAKED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7746748 ↗
Other INTRODUCER, CATHETER devices
- VIZIGO D138502Biosense Webster Inc · INTRODUCER, CATHETER2 recalls4 deaths2,839 reports
- VIZIGO D138501Biosense Webster Inc · INTRODUCER, CATHETER2 recalls2 deaths2,005 reports
- Swartz™ 407451St. Jude Medical, Inc. · INTRODUCER, CATHETER5 deaths728 reports
- Edwards eSheath+ Introducer set 914ESPEdwards Lifesciences LLC · Introducer, Catheter22 deaths532 reports
- Fast-Cath™ 406849St. Jude Medical, Inc. · INTRODUCER, CATHETER420 reports
- VIZIGO D138503Biosense Webster Inc · INTRODUCER, CATHETER362 reports
- Agilis™ G408318St. Jude Medical, Inc. · INTRODUCER, CATHETER333 reports
- Agilis™ NxT Steerable Introducer Dual-Reach™ SI-1371-MSt. Jude Medical, Inc. · Introducer, catheter1 death301 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page